SELLAS Life Sciences Group EPS Basic from Accounting Change (Quarterly) Insights

SELLAS Life Sciences Group, Inc. (SLS)

3.35 +0.48 (+16.72%) USD | NASDAQ | Dec 29, 16:00

3.32 -0.03 (-0.90%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for SLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Geron Corp.	--
ADMA Biologics, Inc.	--
Lyell Immunopharma, Inc.	--
NovaBay Pharmaceuticals, Inc.	--